Stephen P Ackland

8PUBLICATIONS
7CO-AUTHORS
Molecular targetsRadiation therapyPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 11, 2025
Implementing DPYD genotyping to predict chemotherapy toxicity in Australia: a feasibility study.

Cassandra White, Christine Paul, Esther Liet

|Jul 04, 2024
Evaluation of early fluoropyrimidine toxicity in solid organ cancer patients: a retrospective observational study in Australia.

Cassandra White, Guy Kendall, Tegan Millington

|May 22, 2024
Risk factors, histopathological landscape, biomarkers, treatment patterns and survival of early-onset colorectal cancer: A narrative review.

Celine Garrett, Daniel Steffens, Stephen Ackland

|May 10, 2023
Reply to "Implementation of DPYD Genotyping in Admixed American Populations: Brazil as a Model Case".

Cassandra White, Rodney J Scott, Christine Paul

|May 24, 2022
Dihydropyrimidine Dehydrogenase Deficiency and Implementation of Upfront DPYD Genotyping.

Cassandra White, Rodney J Scott, Christine Paul

|Apr 19, 2020
Advanced Adrenocortical Carcinoma (ACC): a Review with Focus on Second-Line Therapies.

Luke Ardolino, Aaron Hansen, Stephen Ackland

Pageof 2